LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.21 | 84.90 | 861 | 2091 | 0.4117 | 0.6506 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.21 | 84.90 | 2153 | 2091 | 1.0294 | 1.0126 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.21 | 84.90 | 91 | 2091 | 0.0435 | 0.0151 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 28.21 | 84.90 | 2238 | 2091 | 1.0700 | 1.0295 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.92 | 84.90 | 1824 | 2237 | 0.8151 | 0.9152 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.92 | 84.90 | 2340 | 2237 | 1.0457 | 1.0190 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.92 | 84.90 | 113 | 2237 | 0.0505 | 0.0625 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.92 | 84.90 | 2380 | 2237 | 1.0636 | 1.0263 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.62 | 84.90 | 2340 | 2449 | 0.9552 | 0.9812 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.62 | 84.90 | 2547 | 2449 | 1.0397 | 1.0161 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.62 | 84.90 | 123 | 2449 | 0.0502 | 0.0794 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 31.62 | 84.90 | 2580 | 2449 | 1.0532 | 1.0215 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.32 | 84.90 | 2674 | 2722 | 0.9822 | 0.9928 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.32 | 84.90 | 2827 | 2722 | 1.0384 | 1.0151 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.32 | 84.90 | 169 | 2722 | 0.0621 | 0.1475 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 33.32 | 84.90 | 2802 | 2722 | 1.0292 | 1.0116 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 35.03 | 84.90 | 2966 | 2991 | 0.9915 | 0.9967 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 35.03 | 84.90 | 3085 | 2991 | 1.0313 | 1.0120 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 35.03 | 84.90 | 217 | 2991 | 0.0725 | 0.2004 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 35.03 | 84.90 | 3097 | 2991 | 1.0353 | 1.0136 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 84.90 | 3221 | 3254 | 0.9898 | 0.9961 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 84.90 | 3305 | 3254 | 1.0156 | 1.0059 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 84.90 | 223 | 3254 | 0.0685 | 0.2015 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 84.90 | 3316 | 3254 | 1.0190 | 1.0072 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.43 | 84.90 | 3429 | 3459 | 0.9911 | 0.9967 | MN20160318_Q02 | H11 |